genetic diseases

Sanofi acquires 12pct in Alnylam Pharmaceuticals and drugs for $700M

Sanofi will be purchasing a 12% stake in Alnylam Pharmaceuticals as well as access to the drugs it has developed for rare diseases, Bloomberg reported.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics